
Voyageur Pharmaceuticals Announces IRR of 137% & NPV of $344 Million from PEA for the Frances Creek Barium Project
Voyageur Pharmaceuticals Announces $3.38 per share Valuation Voyageur Pharmaceuticals Ltd (TSX:VM) CALGARY, ALBERTA, CANADA, January 11, 2022 /EINPresswire.com/ -- Voyageur Pharmaceuticals Ltd. (“Voyageur” or the “Company”) (TSX-V:VM) is pleased to …